• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELWEAVE; GELWEAVE GELATIN IMPREGNATED VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELWEAVE; GELWEAVE GELATIN IMPREGNATED VASCULAR GRAFT Back to Search Results
Model Number GELWEAVE
Device Problem Material Integrity Problem (2978)
Patient Problem Hemorrhage/Bleeding (1888)
Event Type  malfunction  
Manufacturer Narrative
Health effect clinical code# 1888, minor blood loss through the graft during the revision surgery to the aortic arch site.Health effect impact code #4613, minor injury, minor blood loss.(b)(4).Type of investigation# 4109, historical data analysis - similar event review relating to the gelweave brand of devices identified an incidence rate of (b)(4).#4111 - communications/interviews - additional discussions with the patients family are expected to gain additional information.(b)(4).Investigation findings code# 3233, results pending completion of investigation - investigation is ongoing.
 
Event Description
Approximately two years ago, a gelweave graft was implanted within a patient in the usa.The patient now resides in (b)(6).Gelweave type product reported to be leaking by the patient / family.Information provided by the family is as follows: the patient underwent a procedure to treat disease progression within the aortic arch which required open surgery.During this procedure, the original graft (gelweave) situated within the ascending aorta began weeping (not at the anastomosis sites).Blood loss was recorded as 10ml/min.The weeping resolved on its own without intervention.The patient tolerated the blood loss, and was transferred to icu to recover.
 
Event Description
Approximately two years ago, a gelweave graft was implanted within a patient in the usa.The patient now resides in india.Gelweave type product reported to be leaking by the patient/family.Information provided by the family is as follows: the patient underwent a procedure to treat disease progression within the aortic arch which required open surgery.During this procedure, the original graft (gelweave) situated within the ascending aorta began weeping (not at the anastomosis sites).Blood loss was recorded as 10ml/min.The weeping resolved on its own without intervention.The patient tolerated the blood loss and was transferred to icu to recover.
 
Manufacturer Narrative
Section h6: health effect clinical code - #1888 - minor blood loss through the graft during the revision surgery to the aortic arch site.Health effect impact code - #4613 - minor injury - minor blood loss.Medical device problem code - #2978 - material integrity issue - the graft is reported to have leaked during a procedure that was not related to this graft.Component code - #4755 - part/component/sub-assembly term not applicable - no known device type.Type of investigation - #4109 - historical data analysis - (b)(4).Type of investigation -#4111 - communications/interviews - additional discussions with the patients family are expected to gain additional information.Type of investigation -#4114 - device not returned - no device is available for evaluation as it remains in situ within the patients anatomy.Investigation findings code - #3221 - no findings available - no additional device or procedural information has been providedby the reporter despite multiple attempts.Investigation conclusion code - #4315 - cause not established.Vascutek considers this event as closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE
Type of Device
GELWEAVE GELATIN IMPREGNATED VASCULAR GRAFT
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
MDR Report Key10565226
MDR Text Key208204058
Report Number9612515-2020-00010
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 10/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberGELWEAVE
Was Device Available for Evaluation? No
Date Manufacturer Received08/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-